샘플 요청 목록

 카트 문의
시장보고서
상품코드
1784835

세계의 유리화 시장

Vitrification
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 278 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유리화 세계 시장은 2030년까지 221억 달러에 달할 전망

2024년에 92억 달러로 추정되는 유리화 세계 시장은 2024-2030년 분석 기간 동안 CAGR 15.7%로 성장하여 2030년에는 221억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석한 부문 중 하나인 난모세포는 CAGR 16.5%를 기록하며 분석 기간 종료시에는 125억 달러에 달할 것으로 예측됩니다. 디바이스 분야의 성장률은 분석 기간 동안 CAGR 14.0%로 추정됩니다.

미국 시장은 25억 달러, 중국은 CAGR 20.9%로 성장 예측

미국의 유리화 시장은 2024년에 25억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 48억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 20.9%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 11.5%와 14.1%로 예측됩니다. 유럽에서는 독일이 CAGR 약 12.5%로 성장할 것으로 예측됩니다.

세계 유리화 시장 - 주요 동향 및 촉진요인 정리

유리화가 냉동보존의 획기적인 기술로 떠오르고 있는 이유는 무엇일까?

유리화는 냉동 보존 분야에 혁명을 일으켜 배아, 난자, 줄기세포, 조직 등 생물학적 표본을 보존할 수 있는 매우 효율적인 방법을 제공하고 있습니다. 기존의 느린 동결 기술과 달리 유리화는 세포 구조에 손상을 입히는 얼음 결정을 형성하지 않고 생물학적 물질을 유리와 같은 상태로 빠르게 냉각시킵니다. 이 첨단 냉동보존법은 보조생식술(ART), 특히 체외수정(IVF) 클리닉에서 널리 사용되고 있으며, 생존율이 매우 높은 배아 및 난자 보존에 활용되고 있습니다. 부모가 되는 시기가 늦어지는 추세, 생식능력에 영향을 미치는 치료, 생식 의료의 발전 등으로 생식능력 보존에 대한 수요가 증가함에 따라 ART 치료에서 유리화의 필요성이 증가하고 있습니다. 또한, 유리화는 재생의료, 바이오뱅크, 장기 이식 연구에서 중요한 역할을 하고 있습니다. 생존 가능한 생물학적 물질의 장기 보존은 미래의 의료적 돌파구를 위해 필수적입니다. 극저온 생물학에 대한 과학적 이해가 발전함에 따라 유리화는 여러 의료 및 연구 분야에서 냉동 보존의 표준이 될 것으로 예상됩니다.

기술의 발전은 유리화 기술을 어떻게 향상시키고 있는가?

냉동 보존 기술의 끊임없는 기술 혁신으로 유리화 효율, 생존율, 보존 능력이 크게 향상되었습니다. 초급속 냉각 기술과 첨단 동결보호제 용액 개발로 해동 후 생존율을 높이면서 세포 손상의 위험을 최소화하고 있습니다. 자동화된 유리화 시스템도 도입되어 불임클리닉이나 연구소의 인위적인 실수를 줄이고 동결 절차를 표준화하고 있습니다. 또한, 폐쇄형 유리화 장치와 같은 냉동 보존 시스템의 개선은 오염 문제를 해결하고 보존된 생물학적 시료의 무균성과 장기적인 안전성을 보장합니다. 나노기술은 유리화 연구에서도 새로운 역할을 하고 있으며, 과학자들은 동결 및 해동 시 세포의 무결성을 더욱 향상시킬 수 있는 나노 강화 동결 보호제를 연구하고 있습니다. 또한, AI를 통한 동결보존 프로토콜의 최적화를 통해 연구자와 임상의가 개별 생물학적 특성에 따라 동결 조건을 맞춤화하여 유리화 결과를 향상시킬 수 있도록 돕습니다. 이러한 기술적 진보는 유리화의 신뢰성을 향상시킬 뿐만 아니라 재생의료, 유전자 보존, 장기 이식 연구로의 응용 가능성을 넓히고 있습니다.

유리화 동결보존의 도입을 가로막는 과제는 무엇인가?

유리화는 기존 냉동 방식에 비해 우수한 효율을 가지고 있음에도 불구하고, 의료 및 연구 현장에서의 보급에 영향을 미치는 몇 가지 과제에 직면해 있습니다. 주요 장애물 중 하나는 유리화 장비, 특수 냉동 보호제, 냉동 보존 시설과 관련된 높은 비용으로, 자원이 부족한 의료 환경에서는 이용하기 어렵습니다. 또한, 이 기술은 고도의 전문성과 정확성을 요구하기 때문에 일관된 결과를 얻기 위해서는 배아배양사, 생물학자, 검사 기술자에 대한 광범위한 교육이 필요합니다. 또 다른 과제는 인간 배아 및 생식세포의 장기보존을 둘러싼 윤리적, 법적 인사이트에 있습니다. 또한, 장기 보존에 따른 유리화 세포의 유전적, 구조적 무결성에 대한 우려는 현재도 연구 중인 분야입니다. 이러한 문제를 해결하기 위해서는 비용 효율적인 냉동 보존 방법의 지속적인 발전, 표준화된 훈련 프로토콜, 유리화 생물 시료의 장기 생존성에 대한 보다 종합적인 연구가 필요합니다.

유리화 시장의 성장을 촉진하는 요인은 무엇인가?

유리화 시장의 성장은 불임 치료 수요 증가, 재생의료의 발전, 바이오뱅크 및 유전자 연구 확대 등 여러 요인에 의해 이루어지고 있습니다. 전 세계적으로 불임의 유병률 증가와 체외수정 치료의 수용 확대는 생식 의료 분야에서 유리화 채택에 크게 기여하고 있습니다. 또한, 줄기세포 치료 및 장기 보존 연구의 확대로 인해 미래의 의료 응용을 위해 세포의 생존성을 유지하는 신뢰할 수 있는 냉동 보존 방법에 대한 수요가 증가하고 있습니다. 현재 진행 중인 맞춤형 의료와 유전자 보존 솔루션의 개발은 생물학적 다양성과 희귀 유전 물질을 보존하기 위한 중요한 도구로서 유리화에 대한 관심을 더욱 높이고 있습니다. 동결 보호제, 자동화, AI를 통한 동결 최적화의 끊임없는 혁신으로 유리화 시장은 크게 성장하여 생식 의료, 생의학 연구, 장기 생물학적 보존의 미래를 형성하고 있습니다.

부문

검체(난자, 디바이스, 정자), 최종사용(IVF 클리닉, 바이오뱅크)

조사 대상 기업 사례

  • Biotech, Inc.
  • Cook Medical, LLC
  • CooperSurgical, Inc.
  • Cryoport Systems, Inc.
  • Fertipro NV
  • FUJIFILM Irvine Scientific d/b/a FUJIFILM Biosciences
  • Genea Biomedx
  • GYNEMED GmbH & Co. KG
  • Imv Technologies S.A.
  • KITAZATO CORPORATION

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.13

Global Vitrification Market to Reach US$22.1 Billion by 2030

The global market for Vitrification estimated at US$9.2 Billion in the year 2024, is expected to reach US$22.1 Billion by 2030, growing at a CAGR of 15.7% over the analysis period 2024-2030. Oocytes, one of the segments analyzed in the report, is expected to record a 16.5% CAGR and reach US$12.5 Billion by the end of the analysis period. Growth in the Devices segment is estimated at 14.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 20.9% CAGR

The Vitrification market in the U.S. is estimated at US$2.5 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 20.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.5% CAGR.

Global Vitrification Market - Key Trends & Drivers Summarized

Why Is Vitrification Emerging as a Breakthrough in Cryopreservation?

Vitrification has revolutionized the field of cryopreservation, offering a highly efficient method for preserving biological specimens such as embryos, oocytes, stem cells, and tissues. Unlike traditional slow-freezing techniques, vitrification rapidly cools biological materials to a glass-like state without forming ice crystals, which can damage cellular structures. This advanced cryopreservation method has gained widespread adoption in assisted reproductive technology (ART), particularly in in-vitro fertilization (IVF) clinics, where it is used to preserve embryos and eggs with significantly higher survival rates. The increasing demand for fertility preservation, driven by delayed parenthood trends, medical treatments affecting fertility, and advancements in reproductive medicine, has fueled the need for vitrification in ART procedures. Additionally, vitrification is playing a crucial role in regenerative medicine, biobanking, and organ transplantation research, where the long-term storage of viable biological materials is essential for future medical breakthroughs. As scientific understanding of cryobiology continues to advance, vitrification is expected to become the gold standard for cryopreservation across multiple medical and research applications.

How Are Technological Advancements Improving Vitrification Techniques?

Continuous innovations in cryopreservation technology have led to significant improvements in vitrification efficiency, survival rates, and storage capabilities. The development of ultra-rapid cooling techniques and advanced cryoprotectant solutions has minimized the risks of cellular damage while enhancing post-thaw viability. Automated vitrification systems have also been introduced, reducing human error and standardizing freezing procedures in fertility clinics and research laboratories. Additionally, improvements in cryo-storage systems, such as closed-system vitrification devices, have addressed contamination concerns, ensuring the sterility and long-term safety of stored biological samples. Nanotechnology is also playing an emerging role in vitrification research, with scientists exploring nano-enhanced cryoprotectants that further improve cell integrity during freezing and thawing. Moreover, AI-driven optimization of cryopreservation protocols is enhancing vitrification outcomes, allowing researchers and clinicians to customize freezing conditions based on individual biological characteristics. These technological advancements are not only improving the reliability of vitrification but also expanding its potential applications in regenerative medicine, genetic preservation, and organ transplantation research.

What Challenges Are Hindering the Adoption of Vitrification in Cryopreservation?

Despite its superior efficiency compared to traditional freezing methods, vitrification faces several challenges that impact its widespread implementation in medical and research settings. One of the primary obstacles is the high cost associated with vitrification equipment, specialized cryoprotectants, and cryo-storage facilities, making it less accessible in low-resource healthcare environments. Additionally, the technique requires a high level of expertise and precision, necessitating extensive training for embryologists, biologists, and laboratory technicians to achieve consistent results. Another challenge lies in the ethical and legal considerations surrounding the long-term storage of human embryos and reproductive cells, as different countries have varying regulations governing cryopreservation practices. Furthermore, concerns regarding the potential genetic and structural integrity of vitrified cells over extended storage periods remain an area of ongoing research. Addressing these challenges will require continued advancements in cost-effective cryopreservation methods, standardized training protocols, and more comprehensive studies on the long-term viability of vitrified biological specimens.

What Factors Are Driving the Growth of the Vitrification Market?

The growth in the vitrification market is driven by several factors, including the increasing demand for fertility preservation, advancements in regenerative medicine, and the expansion of biobanking and genetic research. The rising global prevalence of infertility and the growing acceptance of IVF treatments have significantly contributed to the adoption of vitrification in reproductive medicine. Additionally, the expansion of stem cell therapies and organ preservation research has increased the demand for reliable cryopreservation methods that maintain cellular viability for future medical applications. The ongoing development of personalized medicine and genetic storage solutions has further fueled interest in vitrification as a critical tool for preserving biological diversity and rare genetic materials. With continuous innovations in cryoprotectants, automation, and AI-driven cryo-optimization, the vitrification market is poised for substantial growth, shaping the future of reproductive health, biomedical research, and long-term biological preservation.

SCOPE OF STUDY:

The report analyzes the Vitrification market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Specimen (Oocytes, Devices, Sperm); End-Use (IVF Clinics, Biobanks)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Biotech, Inc.
  • Cook Medical, LLC
  • CooperSurgical, Inc.
  • Cryoport Systems, Inc.
  • Fertipro NV
  • FUJIFILM Irvine Scientific d/b/a FUJIFILM Biosciences
  • Genea Biomedx
  • GYNEMED GmbH & Co. KG
  • Imv Technologies S.A.
  • KITAZATO CORPORATION

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Vitrification - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Accelerating Demand for Fertility Preservation Solutions Drives Adoption of Vitrification Technologies
    • Breakthroughs in Cryobiology Research Strengthen the Scientific Case for Vitrification Over Slow Freezing
    • Rising IVF Success Rates Through Vitrification Expands Addressable Market in Assisted Reproductive Technologies
    • Increasing Oncology Cases and Fertility Preservation Among Cancer Patients Spurs Growth in Medical Applications
    • Growing Demand for Oocyte and Embryo Banking Throws the Spotlight on Vitrification as the Preferred Cryopreservation Method
    • Technological Advancements in Cryoprotectants and Warming Protocols Enhance Viability and Post-Thaw Survival
    • Regulatory Approvals and Guidelines for Embryo and Gamete Storage Boost Clinical Adoption of Vitrification
    • Expansion of Egg Donation and Surrogacy Programs Generates Accelerated Demand for Vitrification-Based Cryostorage
    • Rising Global Awareness of Fertility Options Among Women in Career-Oriented Demographics Drives Uptake
    • Increased Usage of Vitrification in Livestock Embryo Preservation Propels Agricultural and Veterinary Applications
    • Integration of Vitrification with Time-Lapse Imaging and AI-Driven Embryo Selection Optimizes IVF Outcomes
    • Surge in Cross-Border Reproductive Care Expands Global Demand for Safe and Efficient Cryostorage
    • Demand for Long-Term Cell and Tissue Preservation in Stem Cell and Regenerative Medicine Sustains Market Growth
    • Emergence of Portable Vitrification Devices Spurs Decentralized Cryopreservation Capabilities in Remote Clinics
    • Growth of Fertility Tech Startups and Cryobank Infrastructure Strengthens Business Case for Market Investment
    • Collaborative Research on Cryopreservation of Organoids and 3D Cell Cultures Expands Therapeutic Use Cases
    • Adoption of Vitrification for Sperm Preservation in High-Performance Animal Breeding Opens New Revenue Streams
    • Ethical, Legal, and Storage Duration Considerations Create Challenges and Opportunities for Policy Innovation
    • Use of Vitrification in Preservation of Endangered Species Strengthens Conservation Biology Applications
    • Demand for Cost-Effective Cryopreservation Solutions in Emerging Markets Drives Technology Localization
    • Rising Investments in Cell Therapy Manufacturing Infrastructure Throws the Spotlight on Vitrification's Role in Biobanking
    • Public and Private Initiatives to Expand Reproductive Health Services Propel Adoption of Vitrification in Clinical Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Vitrification Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Vitrification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Vitrification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Oocytes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Oocytes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Oocytes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Sperm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Sperm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Sperm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for IVF Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for IVF Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for IVF Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biobanks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biobanks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • JAPAN
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • CHINA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • EUROPE
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Vitrification by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Vitrification by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • FRANCE
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • GERMANY
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Vitrification by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • INDIA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Vitrification by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Vitrification by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Vitrification by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Vitrification by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Vitrification by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030
  • AFRICA
    • Vitrification Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Vitrification by Specimen - Oocytes, Devices and Sperm - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Vitrification by Specimen - Oocytes, Devices and Sperm Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Vitrification by Specimen - Percentage Breakdown of Value Sales for Oocytes, Devices and Sperm for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Vitrification by End-Use - IVF Clinics and Biobanks - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Vitrification by End-Use - IVF Clinics and Biobanks Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Vitrification by End-Use - Percentage Breakdown of Value Sales for IVF Clinics and Biobanks for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제